Transgene SA/ FR0005175080 /
| 2024-04-25 11:16:55 AM | Chg. -0.044 | Volume | Bid11:25:59 AM | Ask11:27:08 AM | High | Low |
|---|---|---|---|---|---|---|
| 1.302EUR | -3.27% | 15,909 Turnover: 21,024.350 |
1.300Bid Size: 8,071 | 1.330Ask Size: 100 | 1.346 | 1.300 |
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-24
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024
GlobeNewswire
04-22
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Th...
GlobeNewswire
04-22
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the Am...
GlobeNewswire
04-22
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene...
GlobeNewswire
04-19
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
GlobeNewswire
04-16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-10
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Dis...
GlobeNewswire
04-09
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Ne...
GlobeNewswire
04-08
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and...
GlobeNewswire
04-08
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform T...
GlobeNewswire
04-04
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AA...
GlobeNewswire
03-28
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cy...
GlobeNewswire
03-27
Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financi...
GlobeNewswire
03-27
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human...
GlobeNewswire
03-21
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...
GlobeNewswire
03-14
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
03-13
Atsena Therapeutics Announces Initiation of Dosing in Second Cohort of Phase I/II Clinical Trial Eva...
GlobeNewswire
03-12
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Du...
GlobeNewswire
03-12
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effe...
GlobeNewswire
03-06
Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024
